Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 0 | 202 | 120 |
| Gross Profit | N/A | N/A | N/A | 202 | 120 |
| Operating Expenses | 2,698 | 2,595 | 2,138 | 11,148 | 15,158 |
| Operating Income | -2,698 | -2,595 | -2,138 | -10,946 | -15,038 |
| Interest Expense | 0 | 0 | 0 | 1 | 2 |
| Other Income | 29 | 26 | 33 | 401 | 646 |
| Pre-tax Income | -2,669 | -2,569 | -2,105 | -10,546 | -14,394 |
| Income Tax | N/A | N/A | N/A | -23 | -6,991 |
| Net Income Continuous | -2,669 | -2,569 | -2,105 | -10,523 | -7,403 |
| Minority Interests | N/A | N/A | 750 | N/A | N/A |
| Net Income | $-2,669 | $-2,569 | $-2,855 | $-10,523 | $-7,403 |
| EPS Basic Total Ops | -2.56 | -2.47 | -2.13 | -2.52 | -1.80 |
| EPS Basic Continuous Ops | -1.99 | -1.91 | -1.57 | -2.54 | -1.79 |
| EPS Diluted Total Ops | -2.56 | -2.47 | -2.13 | -2.52 | -1.80 |
| EPS Diluted Continuous Ops | -1.99 | -1.91 | -1.57 | -2.54 | -1.79 |
| EBITDA(a) | $-2,695 | $-2,586 | $-2,127 | $-10,702 | $-14,774 |